Innovation Directory – Wales

Carleton Medical is a supplier of surgical lasers to both the NHS and private medical sector

CatSci offer chemical, manufacturing and control (CMC) services to pharmaceutical companies. Services include both early and late-stage development of small molecule drugs, as well as research, development and manufacturing of oligonucleotides and RNA-based therapeutics.

Cedar (part of Cardiff University and Cardiff and Vale University Health Board) focuses on the evaluation of medical devices and diagnostics, working with the NHS, academic institutions, commercial sector, publicly funded organisations, and charities.

Cefndy manufactures and supplies aids for disabled people, including grab rails, wheelchairs, shower chairs and stools, slings and dementia care products.

CellPath manufactures and supplies histology, pathology and cytology products, including equipment and consumables. In 2022, CellPath was acquired by US-based StatLab Medical Products

Celtic SMR supplies diagnostic and therapeutic solutions to the healthcare and veterinary industries. Products include X-ray equipment, portable and stationary X-Ray systems, diagnostic ultrasounds and magnetotherapy

Celtic Therapy and Rehab Services are a supplier of wheelchairs and seats, and are able to provide bespoke modifications.

Central Biotechnology Services are a technology facility within Cardiff University that offer access to life science research facilities and services, including cellular analysis, protein expression assays and genomic analysis.

CEMET (based within the University of South Wales) provide tech-based Welsh companies located in Swansea, Neath Port Talbot, Carmarthenshire, Powys, Caerphilly, or the Vale of Glamorgan with access to funded 6-8 week R&D projects to develop products or services in fields including Machine Learning, AI, virtual reality and the Internet of Things.

Ceridwen Oncology is an oncology drug discovery company, targeting rare cancers that currently have no effective treatment options such as chordoma. The company combines structural biology with high throughput in silico drug candidate screening to enable the discovery of a new pipeline of pharmaceuticals.